Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli
Research output: Contribution to journal › Article › peer-review
Standard Standard
Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli. / Roberts, G.T.; Davies, Melanie; Wakeman, J.
In: British Journal of Cancer, Vol. 88, No. 2, 27.01.2003, p. 202-205.
In: British Journal of Cancer, Vol. 88, No. 2, 27.01.2003, p. 202-205.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Roberts, GT, Davies, M & Wakeman, J 2003, 'Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli', British Journal of Cancer, vol. 88, no. 2, pp. 202-205. https://doi.org/10.1038/sj.bjc.6600732
APA
Roberts, G. T., Davies, M., & Wakeman, J. (2003). Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli. British Journal of Cancer, 88(2), 202-205. https://doi.org/10.1038/sj.bjc.6600732
CBE
Roberts GT, Davies M, Wakeman J. 2003. Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli. British Journal of Cancer. 88(2):202-205. https://doi.org/10.1038/sj.bjc.6600732
MLA
Roberts, G.T., Melanie Davies and J. Wakeman. "Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli". British Journal of Cancer. 2003, 88(2). 202-205. https://doi.org/10.1038/sj.bjc.6600732
VancouverVancouver
Roberts GT, Davies M, Wakeman J. Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli. British Journal of Cancer. 2003 Jan 27;88(2):202-205. doi: 10.1038/sj.bjc.6600732
Author
RIS
TY - JOUR
T1 - Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli
AU - Roberts, G.T.
AU - Davies, Melanie
AU - Wakeman, J.
PY - 2003/1/27
Y1 - 2003/1/27
KW - ONCOLOGY
U2 - 10.1038/sj.bjc.6600732
DO - 10.1038/sj.bjc.6600732
M3 - Article
VL - 88
SP - 202
EP - 205
JO - British Journal of Cancer
JF - British Journal of Cancer
SN - 0007-0920
IS - 2
ER -